Urinary bladder cancer (UBC) patients at muscle invasive stage have poor clinical outcome,
due to high propensity for metastasis. Cancer-associated fibroblasts (CAFs), one of the …

Simple Summary Non-muscle-invasive bladder cancer is associated with its high rates of
progression and recurrence, the proper diagnosis and management can save lives. Bladder …

Purpose: Tumor hypoxia is associated with a poor prognosis, hypoxia modification improves
outcome, and hypoxic status predicts benefit from treatment. Yet, there is no universal …

Background: Bladder cancer (BC) predominantly affects the elderly and is often the cause of
death among patients with muscle-invasive disease. Clinicians lack quantitative estimates of …

Bladder cancer (BC) is a heterogeneous disease. Approximately 75% of patients present
with non-muscle-invasive BC (NMIBC), which has a high recurrence rate and a low but …

Purpose: Previous study identified E2F1 as a key mediator of non–muscle-invasive bladder
cancer (NMIBC) progression. The aim of this study was to identify the E2F1-related genes …

Our study's goal was to screen novel biomarkers that could accurately predict the
progression and prognosis of bladder cancer (BC). Firstly, we used the Gene Expression …

ABSTRACT Background Circulating tumor cells (CTCs) provide prognostic information in
patients with metastatic tumors. Recent studies have shown that CTCs are released in …

In this study, we evaluated the reproducibility of abundant urine protein depletion by
hexapeptide-based library beads and an antibody-based affinity column using the iTRAQ …

Background There is no good prognostic model that could predict the prognosis of bladder
cancer (BCa) and the benefit of immunotherapy. Methods Through the least absolute …